# Evaluation of the Patient's Experience in Medical Studies for Cholangiocarcinoma

> **NCT05694845** · — · UNKNOWN · sponsor: **Power Life Sciences Inc.** · enrollment: 500 (estimated)

## Conditions studied

- Cholangiocarcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05694845
- **Lead sponsor:** Power Life Sciences Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-02
- **Primary completion:** 2025-02
- **Final completion:** 2026-02
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2023-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05694845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05694845, "Evaluation of the Patient's Experience in Medical Studies for Cholangiocarcinoma". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05694845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*